zDHHC12 is upregulated in high‐grade serous ovarian cancer (HGSOC) and zDHHC12 knockdown or pharmacological inhibition with 2‐bromo‐palmitate sensitized HGSOC cells to cisplatin treatment in ovarian xenografts and in ascites‐derived organoid of platinum‐resistant ovarian cancer.74 Here, ZDHHC12 is linked to ovarian cancer.